Publications

5538 Results

Prognostic significance of p53 and K-RAS mutations in primary resected non-small cell lung cancer: Preliminary results from a propsective randomized trial of postoperative adjuvant therapy (intergroup trial 0115).

Authors
JH Schiller;S Adak;R Feins;S Keller;W Fry;RB Livingston;B Wolf;J Jett;L Kohman;D Johnson;E Hammond
Journal / Conference
Proc of the American Society of Clinical Oncology 18:464a(#1789)
Year
1999
Research Committee(s)
Lung
Study Number(s)
SWOG-9323 (E4592)

Phase II trial of CI-980 in patients with disseminated malignant melanoma: A Southwest Oncology Group Study.

Authors
RP Whitehead;JM Unger;LE Flaherty;JR Eckardt;SA Taylor;MS Didolkar;W Samlowski;VK Sondak
Journal / Conference
Proc of the American Society of Clinical Oncology 18:554(#2138)
Year
1999
Research Committee(s)
Melanoma
Study Number(s)
S9622

A phase II trial of vinorelbine in relapsed and refractory ovarian cancer - A Southwest Oncology Group study (SWOG-9324).

Authors
ML Rothenberg;PY Liu;WA Nahhas;GR Weiss;LE Schroder;L Elias;S Wilczynski;G Winakur;DS Alberts
Journal / Conference
Proc of the American Society of Clinical Oncology 18:383a(#1480)
Year
1999
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-9324

Cloning and chromosomal localization of the gene encoding human cyclin D-binding Myb-like protein (hDMP1).

Authors
SM Bodner;CW Naeve;KM Rakestraw;BG Jones;VA Valentine;MB Valentine;FW Luthardt;CL Willman;SC Raimondi;JR Downing;MF Roussel;CJ Sherr;AT Look
Journal / Conference
Gene 229:223-228
Year
1999
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9030, SWOG-9034 (EST-3489) (CALGB-9120)

A phase III study of adjuvant radiation therapy (RT), 5-flouorouracil (5-FU), and levamisole (LEV) vs. 5-FU and LEV in selected patients with resected, high risk colon cancer: Initial results of INT 0130.

Authors
J Martenson;C Willett;D. Sargent;J Donohue;R Goldberg;T Wasserman;L Gunderson;R Myerson;P Thomas;B Fisher;A Benson, III
Journal / Conference
Proc of the American Society of Clinical Oncology 18:235a(#904)
Year
1999
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9303 (INT-0130) (NCCTG-91-46-52)

Phase II trial of oral etoposide in recurrent or refractory endometrial adenocarcinoma: A Southwest Oncology Group study

Authors
EA Poplin;PY Liu;JE Delmore;S Wilczynski;DF Moore Jr;RK Potkul;GR Weiss;EV Hannigan;DS Alberts
Journal / Conference
Gynecologic Oncology 74:432-435
Year
1999
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-9212

Immediate hormonal therapy vs observation for node positive prostate cancer following radical prostatectomy and pelvic lymphadenectomy: A randomized phase III Eastern Cooperative Oncology Group/Intergroup trial.

Authors
E Messing;G Wilding;M Sarosdy;D Crawford;J Manola
Journal / Conference
Proc of the American Urological Association :#45
Year
1999
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8793 (EST-3886)

Phase III randomized trial of high-dose chemo (HDC) and stem cell support (SCT) shows no difference in overall survival or severe toxicity compared to maintenance chemo with cyclophosphamide, methotrexate and 5-fluorouracil (CMF) for women w/met brst ca who are responding to conventional induction chemo: The Phila....

Authors
EA Stadtmauer;A O'Neill;LJ Goldstein;P Crifley;KF Mangan;JN Ingle;HM Lazarus;J Erban;C Sickles;JH Glick
Journal / Conference
Proc of the American Society of Clinical Oncology 18:1a(#1)
Year
1999
Research Committee(s)
Breast
Study Number(s)
SWOG-9412

Prostate cancer prevention trial (PCPT) update.

Authors
CA Coltman Jr;IM Thompson Jr;P Feigl
Journal / Conference
European Urology 35:544-547
Year
1999
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Summary of the proceedings of the United States and Japan head and neck cancer clinical trials summit, September 19-20, 1997, Kyoto, Japan

Authors
H Matsuura;DE Schuller;M Fukushima;CA Coltman Jr
Journal / Conference
Journal of Cancer Research and Clinical Oncology 125(7):433-438
Year
1999
Research Committee(s)
Head and Neck